Home  >  Products  >  GPLD1 (glycosylphosphatidylinositol specific phospholipase D1 ) Blocking Peptide (the N terminal of GPLD1)(100ug)
GPLD1 (glycosylphosphatidylinositol specific phospholipase D1 ) Blocking Peptide (the N terminal of GPLD1)(100ug)

GPLD1 (glycosylphosphatidylinositol specific phospholipase D1 ) Blocking Peptide (the N terminal of GPLD1)(100ug)

Supplier: Aviva Systems Biology Incorporated
Star_fadedStar_fadedStar_fadedStar_fadedStar_faded
0 reviews | Write a Review Pencil
This is a synthetic peptide designed for use in combination with anti-GPLD1 Antibody (ARP66366_P050), made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
Reactivities: Human
Presku: AAP66366
Size: 100ug
Weight: 90kDa
Gene: 2822
Format: Lyophilized powder
Target: Many proteins are tethered to the extracellular face of eukaryotic plasma membranes by a glycosylphosphatidylinositol (GPI) anchor. The GPI-anchor is a glycolipid found on many blood cells. The protein encoded by this gene is a GPI degrading enzyme. Glycosylphosphatidylinositol specific phospholipase D1 hydrolyzes the inositol phosphate linkage in proteins anchored by phosphatidylinositol glycans, thereby releasing the attached protein from the plasma membrane.
Alternative names: GPIPLD; GPIPLDM; MGC22590; PIGPLD; PIGPLD1
See Full Product Listings >